This stock no longer trades (delisted May 30, 2023)

Delisted / no longer publicly traded (per market data provider) Everything below is based on the last available data — treat it as historical, not a live read.

Koninklijke DSM N.V.

DSM.AS

Chemicals - Specialty · Basic Materials

Price

€114.05

+0.00 (+0.00%)

Market Cap

€763.7M

Exchange

Euronext Amsterdam

Winston Score

Historical score — this stock no longer trades, so the score is frozen at the last available data.

Data as of Aug 23, 2026 · filings through Dec 31, 2022

How the score breaks down

Quality

Good

Growth

Mixed

Cash Flow

Strong

Stability

Good

Valuation

Weak

Dividends

Mixed

Share count falling — buybacks

−1.5% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 176.3M (2018) → 173.6M (2022)

Winston Score History

The full picture

Koninklijke DSM is a Dutch science and nutrition company that makes ingredients used in food, animal feed, and health products. Its core products include vitamins, nutritional supplements, and specialty chemicals sold to food manufacturers, farmers, and pharmaceutical companies. DSM is one of the world's largest producers of vitamins and nutritional ingredients, and it merged with Swiss flavor company Firmenich in 2023 to form dsm-firmenich.

The company earns money by selling ingredients and solutions to business customers rather than directly to consumers. It operates globally, with a strong presence in Europe, North America, and Asia, and generates roughly several billion euros in annual revenue through the combined entity. Its competitive edge comes from deep scientific expertise and long-term supply contracts, but the business faces real risks from raw material cost swings, pricing pressure from lower-cost Asian competitors, and the ongoing challenge of integrating the large Firmenich merger smoothly.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+53.3% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-56.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

€295M/ year

↓ Declining (-9% vs prior year)

3.5% of revenue

In line with sector average (3%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

0.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€3.1B cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Koninklijke DSM N.V. grew revenue 53% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

29.6%

Modest — 29.6% gross margin

Profit after running costs

Operating Margin

22.7%

Excellent — 22.7% operating margin

Return on the money invested

ROCE

15.1%

Strong — 15.1% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+15.4%

Fast-growing sales (+15.4% YoY)

Profit growth

EPS YoY

-42.3%

Earnings shrinking (-42.3% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

203%

Turns 203% of profit into real cash

Spare cash per sale

FCF Margin

3.8%

Thin free cash flow (3.8%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.28

Conservative — low debt load (0.28)

Covers its interest

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

41.6x

Pricey — P/E 41.6

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

1.49%

Small dividend — 1.49% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

+4.3%

Dividend growing modestly (4.3% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial